Hong Kong Maike Group is a group company mainly engaged in pharmaceutical research and development, brand planning, group management, and pharmaceutical investment. In mainland China, it has more than ten joint ventures and cooperative companies for pharmaceutical production. With high-tech and strict management, it produces GMP-compliant drugs for common and frequently-occurring diseases. Currently, it has a pharmaceutical marketing company — Chongqing Renhe Maike Xindi Pharmaceutical Co., Ltd., for terminal drug marketing; a pharmacy chain company — Chongqing Hongkang Pharmacy Chain Co., Ltd., for terminal drug retail. With the development of the enterprise, in 2014 it acquired controlling shares of the former Sichuan Furui Pharmaceutical Co., Ltd., and newly established Sichuan Maike Furui Pharmaceutical Co., Ltd., as one of Hong Kong Maike's pharmaceutical production bases.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows